# Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS)

> **NCT00805935** · PHASE4 · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 110 (actual)

## Conditions studied

- Polycystic Ovarian Syndrome
- Infertility

## Interventions

- **DRUG:** Menotropin
- **DRUG:** Progesterone vaginal insert
- **DRUG:** Follitropin beta
- **DRUG:** Progesterone in oil
- **DRUG:** leuprolide acetate

## Key facts

- **NCT ID:** NCT00805935
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2010-07
- **Final completion:** 2010-09
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2012-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00805935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00805935, "Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00805935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*